LPL Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $22.1M | Buy |
|
|||||
|
2025
Q2 | $9.89M | Buy |
|
|||||
|
2025
Q1 | $5.58M | Buy |
|
|||||
|
2024
Q4 | $4.37M | Sell |
|
|||||
|
2024
Q3 | $5.17M | Buy |
|
|||||
|
2024
Q2 | $4.53M | Buy |
|
|||||
|
2024
Q1 | $2.54M | Buy |
|
|||||
|
2023
Q4 | $3.2M | Buy |
|
|||||
|
2023
Q3 | $2.79M | Buy |
|
|||||
|
2023
Q2 | $2.83M | Buy |
|
|||||
|
2023
Q1 | $2.95M | Buy |
|
|||||
|
2022
Q4 | $3.28M | Buy |
|
|||||
|
2022
Q3 | $2.65M | Buy |
|
|||||
|
2022
Q2 | $1.72M | Sell |
|
|||||
|
2022
Q1 | $2.71M | Buy |
|
|||||
|
2021
Q4 | $2.69M | Buy |
|
|||||
|
2021
Q3 | $2.47M | Buy |
|
|||||
|
2021
Q2 | $1.74M | Buy |
|
|||||
|
2021
Q1 | $1.28M | Buy |
|
|||||
|
2020
Q4 | $725K | Sell |
|
|||||
|
2020
Q3 | $827K | Buy |
|
|||||
|
2020
Q2 | $788K | Buy |
|
|||||
|
2020
Q1 | $516K | Buy |
|
|||||
|
2019
Q4 | $534K | Buy |
|
|||||
|
2019
Q3 | $350K | Sell |
|
|||||
|
2019
Q2 | $379K | Buy |
|
|||||
|
2019
Q1 | $409K | Buy |
|
|||||
|
2018
Q4 | $222K | Sell |
|
|||||
|
2018
Q3 | $344K | Buy |
|
|||||
|
2018
Q2 | $370K | Buy |
|
|||||
|
2018
Q1 | $435K | Buy |
|
|||||
|
2017
Q4 | $342K | Sell |
|
|||||
|
2017
Q3 | $331K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $280K | Sell |
|
|||||
|
2015
Q4 | $2.06M | Buy |
|
|||||
|
2015
Q3 | $880K | Buy |
|
|||||
|
2015
Q2 | $1.03M | Buy |
|
|||||
|
2015
Q1 | $902K | Buy |
|
|||||
|
2014
Q4 | $777K | Sell |
|
|||||
|
2014
Q3 | $622K | Hold |
|
|||||
|
2014
Q2 | $510K | Sell |
|
|||||
|
2014
Q1 | $1.12M | Buy |
|
|||||
|
2013
Q4 | $829K | Buy |
|
|||||
|
2013
Q3 | $447K | Sell |
|
|||||
|
2013
Q2 | $237K | Buy |
|